These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9642281)

  • 21. Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence.
    Fujimoto N; Katzenellenbogen BS
    Mol Endocrinol; 1994 Mar; 8(3):296-304. PubMed ID: 7517003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway.
    Jakacka M; Ito M; Weiss J; Chien PY; Gehm BD; Jameson JL
    J Biol Chem; 2001 Apr; 276(17):13615-21. PubMed ID: 11278408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-estrogen activity in the yeast transcription system: estrogen receptor mediated agonist response.
    Kohno H; Gandini O; Curtis SW; Korach KS
    Steroids; 1994 Oct; 59(10):572-8. PubMed ID: 7878684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
    Chalbos D; Philips A; Galtier F; Rochefort H
    Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
    Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
    Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of estrogen receptor alpha function and stability by tamoxifen and a critical amino acid (Asp-538) in helix 12.
    Pearce ST; Liu H; Jordan VC
    J Biol Chem; 2003 Feb; 278(9):7630-8. PubMed ID: 12496244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen.
    Cheng J; Zhang C; Shapiro DJ
    Endocrinology; 2007 Oct; 148(10):4634-41. PubMed ID: 17615152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA.
    Anolik JH; Klinge CM; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1993 Dec; 46(6):713-30. PubMed ID: 8274405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen.
    Berry M; Metzger D; Chambon P
    EMBO J; 1990 Sep; 9(9):2811-8. PubMed ID: 2118104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements.
    Klinge CM; Studinski-Jones AL; Kulakosky PC; Bambara RA; Hilf R
    Mol Cell Endocrinol; 1998 Aug; 143(1-2):79-90. PubMed ID: 9806352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
    Cho H; Katzenellenbogen BS
    Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Target specificity of selective estrogen receptor modulators within human endometrial cancer cells.
    Bramlett KS; Burris TP
    J Steroid Biochem Mol Biol; 2003 Jul; 86(1):27-34. PubMed ID: 12943742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nongenomic activity and subsequent c-fos induction by estrogen receptor ligands are not sufficient to promote deoxyribonucleic acid synthesis in human endometrial adenocarcinoma cells.
    Singleton DW; Feng Y; Burd CJ; Khan SA
    Endocrinology; 2003 Jan; 144(1):121-8. PubMed ID: 12488337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen- and antiestrogen-responsiveness of HEC1A endometrial adenocarcinoma cells in culture.
    Castro-Rivera E; Safe S
    J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):287-95. PubMed ID: 9618030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.
    Gielen SC; Burger CW; Kühne LC; Hanifi-Moghaddam P; Blok LJ
    J Soc Gynecol Investig; 2005 Oct; 12(7):e55-67. PubMed ID: 16202921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells.
    Zhang CC; Krieg S; Shapiro DJ
    Mol Endocrinol; 1999 Apr; 13(4):632-43. PubMed ID: 10194768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen-inducible derivatives of hepatocyte nuclear factor-4, hepatocyte nuclear factor-3 and liver factor B1 are differently affected by pure and partial antiestrogens.
    Drewes T; Clairmont A; Klein-Hitpass L; Ryffel GU
    Eur J Biochem; 1994 Oct; 225(1):441-8. PubMed ID: 7925467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Separation and characterization of estrogen independent endometrial cancer cell line originated from Ishikawa strain].
    Shirakawa T; Sakamoto H; Satoh K
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Feb; 48(2):139-46. PubMed ID: 8718550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The promoter of the rat 3-hydroxy-3-methylglutaryl coenzyme A reductase gene contains a tissue-specific estrogen-responsive region.
    Di Croce L; Vicent GP; Pecci A; Bruscalupi G; Trentalance A; Beato M
    Mol Endocrinol; 1999 Aug; 13(8):1225-36. PubMed ID: 10446899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The agonist activity of tamoxifen is inhibited by the short heterodimer partner orphan nuclear receptor in human endometrial cancer cells.
    Klinge CM; Jernigan SC; Risinger KE
    Endocrinology; 2002 Mar; 143(3):853-67. PubMed ID: 11861507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.